The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

Isabelle Bos, Stephanie Vos, Rik Vandenberghe, Philip Scheltens, Sebastiaan Engelborghs, Giovanni Frisoni, Jose Molinuevo, Anders Wallin, Alberto Lleo, Julius Popp, Pablo Martinez-Lage, Alison Baird, Richard Dobson, Cristina Legido-Quigley, Kristel Sleegers, Christine Van Broeckhoven, Lars Bertram, Mara ten Kate, Frederik Barkhof, Henrik ZetterbergSimon Lovestone, Johannes Streffer, Pieter Jelle Visser

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number64
Number of pages9
JournalAlzheimer's Research & Therapy
Volume10
DOIs
Publication statusPublished - 6 Jul 2018

Keywords

  • Alzheimer's disease
  • Biomarkers
  • Multimodal
  • Proteomics
  • Genomics
  • Metabolomics
  • Plasma
  • Magnetic resonance imaging
  • DNA
  • Cerebrospinal fluid
  • CEREBROSPINAL-FLUID BIOMARKERS
  • MILD COGNITIVE IMPAIRMENT
  • BLOOD-BASED BIOMARKERS
  • ALZHEIMERS-DISEASE
  • CSF BIOMARKERS
  • DEMENTIA
  • ATROPHY
  • DIAGNOSIS
  • MRI

Cite this

Bos, Isabelle ; Vos, Stephanie ; Vandenberghe, Rik ; Scheltens, Philip ; Engelborghs, Sebastiaan ; Frisoni, Giovanni ; Molinuevo, Jose ; Wallin, Anders ; Lleo, Alberto ; Popp, Julius ; Martinez-Lage, Pablo ; Baird, Alison ; Dobson, Richard ; Legido-Quigley, Cristina ; Sleegers, Kristel ; Van Broeckhoven, Christine ; Bertram, Lars ; ten Kate, Mara ; Barkhof, Frederik ; Zetterberg, Henrik ; Lovestone, Simon ; Streffer, Johannes ; Visser, Pieter Jelle. / The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. In: Alzheimer's Research & Therapy. 2018 ; Vol. 10.
@article{549140053f70402b8502ca2497971d27,
title = "The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics",
keywords = "Alzheimer's disease, Biomarkers, Multimodal, Proteomics, Genomics, Metabolomics, Plasma, Magnetic resonance imaging, DNA, Cerebrospinal fluid, CEREBROSPINAL-FLUID BIOMARKERS, MILD COGNITIVE IMPAIRMENT, BLOOD-BASED BIOMARKERS, ALZHEIMERS-DISEASE, CSF BIOMARKERS, DEMENTIA, ATROPHY, DIAGNOSIS, MRI",
author = "Isabelle Bos and Stephanie Vos and Rik Vandenberghe and Philip Scheltens and Sebastiaan Engelborghs and Giovanni Frisoni and Jose Molinuevo and Anders Wallin and Alberto Lleo and Julius Popp and Pablo Martinez-Lage and Alison Baird and Richard Dobson and Cristina Legido-Quigley and Kristel Sleegers and {Van Broeckhoven}, Christine and Lars Bertram and {ten Kate}, Mara and Frederik Barkhof and Henrik Zetterberg and Simon Lovestone and Johannes Streffer and Visser, {Pieter Jelle}",
year = "2018",
month = "7",
day = "6",
doi = "10.1186/s13195-018-0396-5",
language = "English",
volume = "10",
journal = "Alzheimer's Research & Therapy",
issn = "1758-9193",
publisher = "BioMed Central Ltd",

}

Bos, I, Vos, S, Vandenberghe, R, Scheltens, P, Engelborghs, S, Frisoni, G, Molinuevo, J, Wallin, A, Lleo, A, Popp, J, Martinez-Lage, P, Baird, A, Dobson, R, Legido-Quigley, C, Sleegers, K, Van Broeckhoven, C, Bertram, L, ten Kate, M, Barkhof, F, Zetterberg, H, Lovestone, S, Streffer, J & Visser, PJ 2018, 'The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics', Alzheimer's Research & Therapy, vol. 10, 64. https://doi.org/10.1186/s13195-018-0396-5

The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics. / Bos, Isabelle; Vos, Stephanie; Vandenberghe, Rik; Scheltens, Philip; Engelborghs, Sebastiaan; Frisoni, Giovanni; Molinuevo, Jose; Wallin, Anders; Lleo, Alberto; Popp, Julius; Martinez-Lage, Pablo; Baird, Alison; Dobson, Richard; Legido-Quigley, Cristina; Sleegers, Kristel; Van Broeckhoven, Christine; Bertram, Lars; ten Kate, Mara; Barkhof, Frederik; Zetterberg, Henrik; Lovestone, Simon; Streffer, Johannes; Visser, Pieter Jelle.

In: Alzheimer's Research & Therapy, Vol. 10, 64, 06.07.2018.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics

AU - Bos, Isabelle

AU - Vos, Stephanie

AU - Vandenberghe, Rik

AU - Scheltens, Philip

AU - Engelborghs, Sebastiaan

AU - Frisoni, Giovanni

AU - Molinuevo, Jose

AU - Wallin, Anders

AU - Lleo, Alberto

AU - Popp, Julius

AU - Martinez-Lage, Pablo

AU - Baird, Alison

AU - Dobson, Richard

AU - Legido-Quigley, Cristina

AU - Sleegers, Kristel

AU - Van Broeckhoven, Christine

AU - Bertram, Lars

AU - ten Kate, Mara

AU - Barkhof, Frederik

AU - Zetterberg, Henrik

AU - Lovestone, Simon

AU - Streffer, Johannes

AU - Visser, Pieter Jelle

PY - 2018/7/6

Y1 - 2018/7/6

KW - Alzheimer's disease

KW - Biomarkers

KW - Multimodal

KW - Proteomics

KW - Genomics

KW - Metabolomics

KW - Plasma

KW - Magnetic resonance imaging

KW - DNA

KW - Cerebrospinal fluid

KW - CEREBROSPINAL-FLUID BIOMARKERS

KW - MILD COGNITIVE IMPAIRMENT

KW - BLOOD-BASED BIOMARKERS

KW - ALZHEIMERS-DISEASE

KW - CSF BIOMARKERS

KW - DEMENTIA

KW - ATROPHY

KW - DIAGNOSIS

KW - MRI

U2 - 10.1186/s13195-018-0396-5

DO - 10.1186/s13195-018-0396-5

M3 - Article

VL - 10

JO - Alzheimer's Research & Therapy

JF - Alzheimer's Research & Therapy

SN - 1758-9193

M1 - 64

ER -